Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is caused by genetics and hormones, diagnosed through examination and biopsy, and treated with medications or surgery.

Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.

Male pattern baldness involves three mechanisms and finasteride can help reverse it.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Minoxidil works faster and is more cost-effective for treating hair loss, but platelet-rich plasma microneedling can be an alternative for those who can't use minoxidil.

Ludwig pattern hair loss in women results from varying sensitivity in hair follicles, causing fewer visible hairs.

Healthy women tend to lose more hair in July and April, and the least in February.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

The model showed that randomness accurately describes individual hair growth cycles and that synchronization can cause large fluctuations not seen in humans.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

All three shampoos reduced dandruff and hair loss, but ketoconazole and piroctone olamine also made hair thicker.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Dutasteride effectively treats hair loss in men who don't respond to finasteride.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

AGA affects many, progresses differently, and early treatment is crucial.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Southern Chinese women with female pattern hair loss have less, thinner hair and smaller hair follicles.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

REVIVV® serum improves hair growth and reduces shedding in androgenetic alopecia.

The document concludes that hair follicles have a complex environment and our understanding of it is growing, but there are limitations when applying animal study findings to humans.

The document concludes that diagnosing hair loss requires evaluating multiple histological features, as no single feature is definitive on its own.

Hair loss severity relates to increased miniaturization in female pattern hair loss.

Trichoscopy is useful for quickly diagnosing different types of hair loss without needing biopsies.

A scalp biopsy revealed systemic amyloidosis in a woman who initially seemed to have a common hair loss condition.